These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 27793635

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of two-phase 18F-sodium-fluoride (18F-NaF) bone PET/CT for evaluating treatment response of bone metastases from breast cancer: Case report.
    Seo JH, Lee SM, Yu SN, Lee JW, Lee JE.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):238-242. PubMed ID: 30665751
    [Abstract] [Full Text] [Related]

  • 5. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT.
    Nakuz TS, Millinger FP, El-Rabadi K, Weber M, Pichler V, Wadsak W, Mitterhauser M, Haug A, Hacker M, Karanikas G, Pietschmann P, Agis H.
    Anticancer Res; 2019 Apr; 39(4):1943-1952. PubMed ID: 30952737
    [Abstract] [Full Text] [Related]

  • 6. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
    Roop MJ, Singh B, Singh H, Watts A, Kohli PS, Mittal BR, Singh G.
    Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210
    [Abstract] [Full Text] [Related]

  • 7. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 May; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 8. F-18 fluoride uptake in primary breast cancer.
    Sarikaya I, Sharma P, Sarikaya A.
    Ann Nucl Med; 2018 Dec; 32(10):678-686. PubMed ID: 30178199
    [Abstract] [Full Text] [Related]

  • 9. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M, Soler M, Riera E, García JR.
    Rev Esp Med Nucl Imagen Mol; 2015 Dec; 34(1):45-8. PubMed ID: 24690280
    [Abstract] [Full Text] [Related]

  • 10. Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.
    Peterson LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, Jenkins I, Lee JH, Shields A, Montgomery S, Linden HM, Gralow J, Gadi VK, Muzi M, Kinahan P, Mankoff D, Specht JM.
    J Nucl Med; 2018 Dec; 59(12):1823-1830. PubMed ID: 29748233
    [Abstract] [Full Text] [Related]

  • 11. A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.
    Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [Abstract] [Full Text] [Related]

  • 12. Prediction of Response to Tumor Necrosis Value-α Blocker Is Suggested by 18F-NaF SUVmax But Not by Quantitative Pharmacokinetic Analysis in Patients With Ankylosing Spondylitis.
    Kim K, Son SM, Goh TS, Pak K, Kim IJ, Lee JS, Kim SJ.
    AJR Am J Roentgenol; 2020 Jun; 214(6):1352-1358. PubMed ID: 32286869
    [Abstract] [Full Text] [Related]

  • 13. Differences in sodium fluoride-18 uptake in the normal skeleton depending on the location and characteristics of the bone.
    Nawata S, Kaneta T, Ogawa M, Ishiwata Y, Kobayashi N, Shishikura-Hino A, Yoshida K, Inaba Y, Saito T, Inoue T.
    Nuklearmedizin; 2017 Jun 12; 56(3):91-96. PubMed ID: 28488727
    [Abstract] [Full Text] [Related]

  • 14. NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy.
    Hardcastle N, Hofman MS, Lee CY, Callahan J, Selbie L, Foroudi F, Shaw M, Chander S, Lim A, Chesson B, Murphy DG, Kron T, Siva S.
    Radiat Oncol; 2019 Sep 05; 14(1):164. PubMed ID: 31488175
    [Abstract] [Full Text] [Related]

  • 15. 18F-sodium fluoride PET/CT in oncology: an atlas of SUVs.
    Sabbah N, Jackson T, Mosci C, Jamali M, Minamimoto R, Quon A, Mittra ES, Iagaru A.
    Clin Nucl Med; 2015 Apr 05; 40(4):e228-31. PubMed ID: 25546225
    [Abstract] [Full Text] [Related]

  • 16. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging.
    Azad GK, Taylor BP, Green A, Sandri I, Swampillai A, Harries M, Kristeleit H, Mansi J, Goh V, Cook GJR.
    Eur J Nucl Med Mol Imaging; 2019 Apr 05; 46(4):821-830. PubMed ID: 30506455
    [Abstract] [Full Text] [Related]

  • 17. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    Lin C, Bradshaw T, Perk T, Harmon S, Eickhoff J, Jallow N, Choyke PL, Dahut WL, Larson S, Humm JL, Perlman S, Apolo AB, Morris MJ, Liu G, Jeraj R.
    J Nucl Med; 2016 Dec 05; 57(12):1872-1879. PubMed ID: 27445292
    [Abstract] [Full Text] [Related]

  • 18. Observer Agreement and Accuracy of 18F-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer.
    Zacho HD, Fonager RF, Nielsen JB, Haarmark C, Hendel HW, Johansen MB, Mortensen JC, Petersen LJ.
    J Nucl Med; 2020 Mar 05; 61(3):344-349. PubMed ID: 31481577
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 18F-NaF PET/CT and 18F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma.
    Zhang Y, Chen Y, Huang Z, Zhang L, Wan Q, Lei L.
    Contrast Media Mol Imaging; 2018 Mar 05; 2018():8271313. PubMed ID: 30254551
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of 18F-FDG and 18F-NaF PET/CT imaging: A novel semi-quantitative assessment of the effects of age and obesity on hip joint inflammation and bone degeneration.
    Yellanki DP, Kothekar E, Al-Zaghal A, Cheng N, Werner TJ, Høilund-Carlsen PF, Alavi A.
    Hell J Nucl Med; 2018 Mar 05; 21(3):181-185. PubMed ID: 30411728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.